Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension.

American Journal of Hypertension
Shelby D ReedHayden B Bosworth

Abstract

The Take Control of Your Blood Pressure trial evaluated the effect of a multicomponent telephonic behavioral lifestyle intervention, patient self-monitoring, and both interventions combined compared with usual care on reducing systolic blood pressure during 24 months. The combined intervention led to a significant reduction in systolic blood pressure compared with usual care alone. We examined direct and patient time costs associated with each intervention. We conducted a prospective economic evaluation alongside a randomized controlled trial of 636 patients with hypertension participating in the study interventions. Medical costs were estimated using electronic data representing medical services delivered within the health system. Intervention-related costs were derived using information collected during the trial, administrative records, and published unit costs. During 24 months, patients incurred a mean of $6,965 (s.d., $22,054) in inpatient costs and $8,676 (s.d., $9,368) in outpatient costs, with no significant differences among the intervention groups. With base-case assumptions, intervention costs were estimated at $90 (s.d., $2) for home blood pressure monitoring, $345 (s.d., $64) for the behavioral intervention ($31 p...Continue Reading

References

Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 22, 2003·JAMA : the Journal of the American Medical Association·Bruce M PsatyNoel S Weiss
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Ihab Hajjar, Theodore A Kotchen
Jan 19, 2005·Family Practice·Knut SchroederTim J Peters
Jan 20, 2005·The Annals of Pharmacotherapy·Rachel A ElliottRob Horne
May 20, 2006·Current Medical Research and Opinion·Andrew J PalmerAndrew J Karter
Sep 26, 2006·Contemporary Clinical Trials·Hayden B BosworthEugene Z Oddone
Dec 29, 2006·PharmacoEconomics·Judith E BosmansMaurits W van Tulder
Mar 31, 2007·Pharmacy World & Science : PWS·Andrew LoweyPeter Hammond
Mar 26, 2008·Archives of Internal Medicine·Karl HorvathAndrea Siebenhofer
Apr 19, 2008·BMJ : British Medical Journal·Judit SimonUNKNOWN Diabetes Glycaemic Education and Monitoring Trial Group

❮ Previous
Next ❯

Citations

Dec 4, 2014·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Hanna Choi, Jeongeun Kim
Apr 30, 2016·International Journal of Technology Assessment in Health Care·Mitchel van EedenSilvia M A A Evers
Oct 14, 2010·American Journal of Hypertension·George S Stergiou, Ioannis A Bliziotis
Apr 23, 2016·American Journal of Preventive Medicine·Steven P DehmerKakoli Roy
Aug 31, 2013·European Journal of Preventive Cardiology·Billingsley KaambwaRichard J McManus
Oct 20, 2015·American Journal of Preventive Medicine·Verughese JacobUNKNOWN Community Preventive Services Task Force
Mar 11, 2017·Journal of Healthcare Management / American College of Healthcare Executives
Jul 31, 2018·International Journal of Technology Assessment in Health Care·Tzeyu L MichaudDejun Su
Feb 13, 2019·Current Hypertension Reports·Nadia Liyanage-DonIan M Kronish
Jul 1, 2011·Expert Review of Cardiovascular Therapy·Lawrence R Krakoff
Apr 30, 2013·Current Hypertension Reports·Leah L ZulligHayden B Bosworth
Nov 2, 2018·Health Care Management Science·Saligrama AgnihothriBalaraman Rajan
Mar 1, 2011·Translational Behavioral Medicine·Hayden B BosworthGeorge L Jackson
Sep 8, 2015·The Cochrane Database of Systematic Reviews·Gerd FlodgrenSasha Shepperd
Nov 24, 2011·Journal of Clinical Nursing·Ryan Shaw, Hayden B Bosworth
Oct 16, 2018·Journal of the American College of Clinical Pharmacy : JAACP·Steven P DehmerKaren L Margolis
Jan 13, 2012·The Journal of Clinical Hypertension·Barry L CarterBeverly B Green
Aug 2, 2014·Revista gaúcha de enfermagem·Anice de Fátima Ahmad BalduinoMarineli Joaquim Meier
Aug 19, 2017·American Journal of Preventive Medicine·Verughese JacobUNKNOWN Community Preventive Services Task Force

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.